Skip to main content

    Matthew Scholz

    Chief Executive Officer

    Oisin BioTechnologies
    Seattle, Washington, United States
    3 investments

    Matthew Scholz is a Chief Executive Officer at Oisin BioTechnologies based in Seattle, Washington, United States. Matthew Scholz has backed 3 companies, including Immusoft, Oisin BioTechnologies and Point B Telematics. Investment focus areas include Android, Software and Biotechnology.

    Sign up to access email, LinkedIn & portfolio

    Portfolio Companies (3)

    IndustryStageWebsite
    1Immusoft————
    2Oisin BioTechnologies————
    3Point B Telematics————
    Showing 1–3 of 3

    Access Full Contact Information

    Get Matthew Scholz's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.

    Email
    LinkedIn
    Portfolio

    No credit card required

    Raising a round? Run your numbers first

    Free tools founders use before pitching investors like this one.